Biohit Oyj’s GastroPanel biomarkers suggested as the first-line method for examination of gastric functions and risk conditions
17.02.2012 12:00
Biohit Oyj's unique GastroPanel examinations diagnose diseases of the stomach
and the risks associated with these diseases. Our quick tests provide diagnosis
of lactose intolerance and Helicobacter
pylori infection, as well as fecal occult blood, a well-known marker for
colorectal cancer. Instruments for analysing the test results belong to our product range, too.
The new over-the-counter products eliminate carcinogenic acetaldehyde thus reducing the risk of cancers of the gastrointestinal tract.
Biohit Oyj sold its liquid handling segment to Sartorius Lab Holding GmbH in December 2011. Read more about Sartorius Biohit Liquid Handling Oy.